PFE · News · 20260914N

COVID Product Demand Decline

PFIZER INC · 2026-09-14 · Importance 26 · Surprise 24

Pfizer continues to face lower demand for COVID-19 products, creating a material headwind for its commercial portfolio. Third-party reporting identifies declining COVID revenue as a key challenge alongside the company’s patent cliff. Pfizer is reportedly shifting attention toward newer products and pipeline assets to offset the erosion in COVID-related demand.

Key facts